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1. Introduction 
The regulation of eukaryotic ornithine decarbox- 
ylase (EC 4.1.1.1 7), the rate-limiting enzyme in the 
biosynthesis of the polyamines putrescine, spermidine 
and spermine, is complex and incompletely under- 
stood. Rapid enzyme activity loss, especially in the 
presence of elevated polyamine levels, is thought o 
involve a small ornithine decarboxylase-regulating 
protein such as the 'ODC-antizyme' of mammalian 
cells [ 1,2 ], or the A-to-B converting factor of Physarum 
polycephalum [3,4]. In this latter, primitive ukaryotic 
system, the ornithine decarboxylase-modulating pro- 
tein is stimulated by polyamines to modify this 
enzyme such that its affinity for the obligate coen- 
zyme, pyridoxal 5'-phosphate (PLP), is severely 
diminished. Thus, even though total ornithine decar- 
boxylase protein is rather stable in Physarum, it is 
rapidly and reversibly converted between the normal 
(A-form) and modified (B-form) states in response to 
external polyamines [5], altered media osmolarity 
[6], protein synthesis inhibitors [7], and normal pro- 
gression through the mitotic cycle [8]. 
The enzyme modification induced by this modu- 
lating protein is therefore believed to be a critical 
control mechanism in normal polyamine biosynthesis. 
Until now, however, we have not been able to demon- 
strate that this in vivo enzyme alteration actually 
does result in an equally rapid change in the enzyme 
catalytic activity within the cell. In these experiments 
we utilized an enzyme-activated irreversible inhibitor 
or ornithine decarboxylase,c~-difluoromethylornithine 
(DFMO) to specifically inactivate the catalytically 
active enzyme within this organism. This study not 
only supports the hypothesis that the B-form of this 
enzyme is catalytically inactive in vivo, but it greatly 
increases our understanding of the cellular esponse 
to this inhibitor. 
In vitro studies uggest ornithine decarboxylase 
accepts DFMO as an alternate substrate [9]. During 
decarboxylation f this analog, however, a highly 
unstable intermediate is formed that alkylates the 
enzyme at or near its catalytic site resulting in inacti- 
vation. The irreversible nature of this specific poly- 
amine synthesis inhibitor has prompted its wide use 
in investigations into the function of cellular poly- 
amines and the control of their biosynthesis [10,11] 
as well as direct medical application in tumor [ 12,13] 
and leukemia [14] chemotherapy and eradication of 
parasitic protozoa [15]. Surprisingly little is actually 
known of DFMO's action against ornithine decarbox- 
ylase in vivo, and it is perplexing that even at high, 
prolonged oses this compound oes not block poly- 
amine synthesis completely [11,1 6,17]. These results 
demonstrate hat cellular ornithine decarboxylase 
may indeed vary widely in sensitivity to DFMO 
depending on the state of the enzyme. 
2. Experimental 
Pyridoxal 5 'phosphate, L-ornithine, 4-(2-hydroxy- 
ethyl)-l-piperazine-propanesulfonic acid (Hepps), 
dithiothreitol, EDTA, and the chloride salts of putres- 
cine and spermidine were purchased from Sigma 
Chemical Co .; and L- [ 1-a4C] ornithine • HC1 (5 0 Ci/mol) 
from Amersham/Searle Corp. D,L-a-Difluoromethyl- 
ornithine (DFMO) was a generous gift from the 
Merrell-National Labs (Cincinatti OH). 
Cultures ofP. polycephalum were maintained and 
sampled as in [18]. Only exponentially-growing shake- 
flask cultures of asynchronous microplasmodia were 
used. 
Microplasmodia (4-5 ml samples) were removed 
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from their culture media by centrifugation at200 × g 
for 30 s and immediately resuspended in 10 m180 mM 
NaC1 in water at 4°C. This was centrifuged again, 
decanted and the pellet frozen in liquid nitrogen. 
The details of the assay procedure have been 
reported [6], A-form enzyme activity was determined 
using 0.01 M Hepps buffer (pH 8.0)/0.5 mM dithio- 
threitol/0.5 mM EDTA/0.5/aM pyridoxal 5 '-phos- 
phate/0.1 mM L- [ 1-14C] ornithine (0.02/aei). Total 
assayable nzyme was determined using pH 8.4 Hepps 
and 100/aM pyridoxal 5'-phosphate along with the 
EDTA and dithiothreitol. The difference between 
these assays was attributed to the B-form enzyme. 
One unit of activity was designated to be l nmol CO2 
released/h. 
Protein concentrations were determined on 50/al 
samples of the crude enzyme homogenates u ing the 
Bio-Rad protein assay, which follows [19]. 
14C-Labeled DFMO was obtained by special con- 
tract with Amersham/Searle Corp. and the Merrell- 
National Labs. Labeled DFMO (1 mCi/mmol) was 
added to the media of exponentially-growing 
Physarum cultures to a final concentration f 0.1 raM. 
Samples (5 ml) were withdrawn immediately after 
label addition, and again 1 h later, and rapidly washed 
6 times in 80 mM NaC1 in water at 4°C. After each 
wash the cellular material was pelleted by centrifuga- 
tion for 20 s at 1000 X g. The washed pellets were 
oven-dried in glass scintillation vials and counted with 
1 ml H20 and 5 ml scintillation cocktail (Research 
Products International 3a70B) at ~40% efficiency. 
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Fig.1. D FMO-inactivation of  ornithine decarboxylase in crude 
homogenates containing two different levels of coenzyme. 
DFMO (0.1 mM) was added to samples of freshly homoge- 
nized Physarum icroplasmodia that were identical except 
one contained 0.25 taM PLP (A) and the other 20/aM PLP (B). 
These crude enzyme fractions were subsequently incubated 
at 25°C, with samples extracted at the indicated times and 
assayed for A-form (o) and B-form (o) activity. 
3. Results 
Since the irreversible inhibition by DFMO is con- 
tingent upon ornithine decarboxylase action on this 
inhibitor, it follows that conditions which limit this 
enzyme's activity will also prevent the inactivation of 
this enzyme. Thus the A-form ofPhysarum omithine 
decarboxylase (which has a KmPLP = 0.05/aM under 
these conditions) is readily inactivated by this inhibi- 
tor in vitro when catalyzed in the presence of either 
0.25 or 20/aM PLP, yet the B-form (which has a 
Km PEP = 12.7/aM) is quite insensitive to DFMO at 
the lower coenzyme l vel (rigA). 
This correlation between functioning enzyme and 
inactivation by DFMO was then used in an attempt to 
determine the relative activities of these two enzyme 
forms in vivo. We anticipated that either both forms 
of this enzyme would be equally sensitive to DFMO 
in vivo, or else only the A-form would be active and 
therefore DFMO sensitive. The addition of 5 mM 
DFMO to cultures of Physarurn resulted in a loss of 
>95% of the total ornithine decarboxylase activity in 
3 h (fig.2). Since these cultures initially contained a 
portion of their enzyme in the B-form (~45% in the 
experiment of fig.2) it appeared at first that this form 
must also be sensitive to DFMO in vivo. However, if 
both forms of this enzyme were equally sensitive to 
cellular DFMO then the rate of enzyme inactivation 
should have been unchanged by conditions which 
induce modification of the enzyme to the B-form. 
Yet the addition of 0.1 mM spermidine,which rapidly 
promotes A-to-B form conversion i  vivo, quickly 
blocked any additional ornithine decarboxylase inac- 
tivation, even in culture pre-exposed to this inhibitor 
for 90 rain (fig.2). 
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Fig.2. In vivo DFMOqnactivation f ornithine decarboxylase. 
DFMO (5.0 mM) was added to the media of two culture flasks 
of exponential-phase Physarum icroplasmodia (.,.). A 
third culture (o) served as a control. After 90 min DFMO 
exposure, 0.1 mM spermidine was also added to one of the 
cultures (-). At the designated times amples were extracted, 
washed, frozen and eventually assayed for both the A- and 
B-forms of this enzyme. The top panel shows the variation in 
A-form enzyme as % of total. The lower panel illustrates the 
loss in total (A + B-form) ornithine decarboxylase activity 
due to DFMO addition. 
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Fig.3. Altered in vivo DFMO sensitivity with respect to the 
form of ornithine decarboxylase. Four exponentially growing 
cultures of Physarum were treated with 0.1 mM spermidine 
to induce the modification of their ornithine decarboxylase 
to predominantly he B-form. After 90 rain 5 mM DFMO was 
added to 2 of these cultures (e,.). After 60 rain of this 
DFMO treatment, when the cultures were still relatively 
insensitive to this inhibitor, one of the DFMO-treated cul- 
tures (m) and one of the controls (o) were centrifuged and 
their cellular material resuspended in culture flasks containing 
distilled water. Samples were assayed and data presented as in 
fig.2. 
Spermidine does not directly inhibit cellular uptake 
of this inhibitor. 14C-Labeled DFMO presented at 
0.1 mM was found to be incorporated at the rate of 
632 +- 53 (11) pmol.  mg protein -1 . h -s, compared 
to 636 4- 32 (5) pmol.  mg protein -1 . h -s, in the 
presence of 1 mM spermidine. Ratl~er, the induction 
of DFMO insensitivity appeared to be directly related 
to the conversion of A-form enzyme to the B-form 
since the elevation of media osmolarity (following 
[6]) or the addition of cyclohexirnide [7] also imme- 
diately blocked enzyme sensitivity to DFMO (not 
shown). 
Conversely, conditions which promoted the con- 
version of omithine decarboxylase B-to-A form in 
vivo resulted in the rapid inactivation of this enzyme 
by DFMO (fig.3). The ornithine decarboxylase of 
Physarum cultures exposed to 1 mM spermidine 
remained predominantly in the B-form and subse- 
quently insensitive to DFMO for many hours. How- 
ever, at 0.1 mM spermidine A-form enzyme began to 
reappear after only ~2.5 h. As shown in fig.3 the 
increase in A-form was closely matched by a decrease 
in total enzyme activity in the presence of DFMO. 
We had shown that very rapid conversion of B- 
form ornithine decarboxylase to A can be induced by 
suspending cells in low ionic strength media [6]. As 
shown in fig.3 the placement ofPhysarum icroptas- 
modia that were pre-exposed to 0.1 mM spermidine 
and DFMO into distilled water, with neither sper- 
midine nor DFM0, resulted in a sudden increase in 
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the A-form of the enzyme. This B-to-A form conver- 
sion was followed closely by unusually rapid inactiva- 
tion of  total ornithine decarboxylase enzyme activity 
in these cells. 
4. Discussion 
These experiments suggest that only the unmodi- 
fied, A-form ofPhysarum ornithine decarboxylase is 
directly inactivated by DFMO in vivo, while the B-form 
of this enzyme must first be converted to A to be sen- 
sitive to this inhibitor. The relative insensitivity of B- 
form enzyme to DFMO strongly supports our previ- 
ously untested contention that the post-translational 
enzyme modification, induced by the A-to-B form 
converting factor, does render this enzyme catalyt- 
icaUy inactive in vivo. 
Since the A-form appears to be much more sensitive 
to DFMO inactivation one might have expected to 
observe the proportion of total enzyme in this form 
to diminish sharply during this inactivation, yet this 
was not ob served here. An explanation fully consistent 
with our observations i  that as the DFMO reacted 
with, and reduced the levels of, catalytically active A 
enzyme form it lowered local, free cellular polyamine 
levels. This is likely to have stimulated additional 
conversion of the B-form of the enzyme to the A-form, 
thereby maintaining, or even increasing (as in fig .2), 
the fraction of  total remaining enzyme in the A-form. 
For example, placement ofPhysarum icroplasmodia 
in low ionic strength media, as in the control culture 
of fig.3, rapidly stimulated almost complete activation 
(B-to-A form conversion) of this enzyme, followed by 
a gradual re-establishment of  60% A-form ratio that is 
normal for a culture of this age in the absence of added 
polyamines. By contrast he DFMO-treated culture, 
which was similarly resuspended and had almost all 
its enzyme converted to the A-form, was greatly lim- 
ited in the amount of  putrescine it could synthesize. 
Therefore, the polyamine-stimulated A-to-B form 
converting factor was not activated in this culture and 
the percent A-form enzyme remained very high. 
It was noted, as in the first 60 min of the experi- 
ment in fig.3, that a small fraction of A-form activity 
remained insensitive to in vivo A-to-B form modifica- 
tion and was similarly not inactivated by DFMO. We 
are now investigating whether this represents a refrac- 
tory state of  a fraction of the A-form enzyme due to 
a constraint within the cell, or conversely, a small 
portion of  cellular B-form enzyme that was activated 
to A-form during tissue homogenization a d enzyme 
isolation. 
Direct extrapolation of these results to mammalian 
tissues is somewhat hindered by the current dearth of 
information on the disposition and reversibility of 
modified ornithine decarboxylase forms in these cells. 
If, as it currently appears, antizyme-bound enzyme or 
perhaps the 'cryptic' form [20] indeed are found to 
represent reversibly inactivated enzyme states imilar 
to Physarum B-form, then we may observe that the 
close correlation between the state of the enzyme and 
its sensitivity to DFMO is a general eukaryotic phe- 
nomenon. Agents which stimulate modification of 
ornithine decarboxylase and temporarily reduce its 
cellular activity would make these enzyme molecules 
relatively insensitive 1o short DFMO exposure or levels 
of this inhibitor that could be quickly reduced by cel- 
lular degradation. Conversely, maximal sensitivity to 
low concentrationsofthis inhibitor should accompany 
enzyme-activating conditions. Indeed, such variable 
sensitivity to DFMO has been reported in human cells 
[17]. Further work along these lines is needed to 
attain greater understanding of the in vivo sensitivity 
of ornithine decarboxylase to DFMO in order to max- 
imize the usefullness of this drug in medicine and 
research. 
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